Harvard medical school in ethics quandary
New York Times, March 3, 2009
A full-blown movement by more than 200 Harvard Medical School students and sympathetic faculty is intent on exposing and curtailing drug industry influence in their classrooms and laboratories, as well as in Harvard's 17 affiliated teaching hospitals and institutes. They say they are concerned that the same money that helped build the school's world-class status may in fact be hurting its reputation and affecting its teaching. The students argue, for example, that Harvard should be embarrassed by the F grade it recently received from a national group that rates how well medical schools monitor and control drug industry money.
Most Viewed
Most Emailed
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- Primary Care Docs Average More Hospital Revenue Than Specialists
- Building a Better Healthcare Board
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Quiet ORs Better for Patient Safety
- Hospital Pricing Data Dump Won't Hurt You, Yet
- CMS Releases Hospital Pricing Data
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- Case Study: Advance Care Conversations
- Telemedicine is Retail Health Clinics' Newest Tool
